Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

A gentle touch: could manual therapy boost hip healing in babies?

NCT ID NCT07756814

Disease control Sponsor: Université de Sherbrooke Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 11, 2026 · Last updated Aug 12, 2026 · Updated 1 time

Summary

This pilot study explores whether a gentle manual therapy applied to the hip bone, in addition to standard treatment with a Pavlik harness, can improve hip joint coverage in infants with developmental dysplasia of the hip (DDH). Thirty infants aged 1 to 5 months with moderate to severe DDH will be randomly assigned to receive either the manual therapy plus standard care or standard care alone. Ultrasound measurements will compare changes in hip coverage before and after the three-week intervention period. The study also aims to assess how acceptable the therapy is to parents, providing preliminary data for a larger future trial.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Gentle manual therapy applied to the hip bone (coxal bone) in infants
What this could lead to
If effective, this gentle manual therapy could complement standard treatment for infant hip dysplasia, potentially improving hip joint development and reducing the need for more invasive interventions.
What could go wrong
This is a small pilot study, so results may not be conclusive. The therapy is experimental, and its benefit over standard care alone is uncertain. There is also a risk of discomfort for the infant during the procedure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Sep 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

1 month to 5 months

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Confirmed diagnosis of DDH, unilateral or bilateral * Graf score between IIa and III (moderate to severe DDH), as stage I may resolve spontaneously * Written parental authorization (or delegated parental representation) providing free and informed consent * Infant already receiving conservative orthopedic care with a Pavlik harness (the study tests a complementary intervention) * Parental availability for the study follow-up Exclusion Criteria: * Presence of severe congenital anomalies * Neuromuscular or genetic diseases affecting muscle tone or bone growth * Cardiorespiratory conditions requiring constant monitoring * Fractures of the pelvis or lower limbs * Prematurity (birth before 37 weeks of gestation) * Medical contraindications to the proposed manual intervention * Ongoing physiotherapy or any manual therapy treatment outside the study framework * Growth retardation (staturo-ponderal), with or without suspected nutritional deficiencies * Infant showing distress or intolerance to physical handling during prior care * Simultaneous participation in another clinical study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Congenital hip dysplasia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

developmental dysplasia of the hip Hip Dislocation, Congenital

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Congenital hip dysplasia Developmental dysplasia of the hip (DDH)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.